BioCentury
ARTICLE | Distillery Therapeutics

Cancer

July 31, 2017 7:19 PM UTC

In vitro and cell culture studies identified a hydrazone-based inhibitor of RRM1 that could help treat breast, colorectal and pancreatic cancers. In silico screening of a small molecule library and te...